RE:RE:RE:RE:You know you're a bagholder when....Chrispi the muppet has all the inside information that can't be shared, except that something big is just about to always happen. Been spouting the same pro-management claptrap for 2+ years and zero has been accomplished to get anything to clinical. ALWAYS 100% wrong, but claims every buried, out of patience and nearly dead shareholder is an idiot. As JD states, since we don't
yet have any programs in the clinic (human dosing) we are really left for (non financial and general company) news generation with:
- any internal studies that we do,
- external studies (not done by us),
- licensing deals
- partnership deals (which I'll also include as MTAs)
We are a small biotech company so it goes without saying that even if we did have programs in the clinic the nature of the business is that there are big gaps in news flow as we wait while dosing is done, many months, even a year or two.
Licensing and partnership deals take time in the biotech world (much more so than other industries) and we were always between a rock and a hard place with poor leadership (when Mark Day was CEO) or lack of funds or COVID delays. What I was expecting the company to accomplish by now has just been extended a bit ... still game on, just a few more extra innings.
I think you’ll see this year what exactly the company has been busy working on for the past two years!